Statins, known as cholesterol-lowing drugs, appear to be linked to lowering the risk of Alzheimer's disease in certain individuals, as published by a study out on Monday. But not every patient benefited, and the report no longer established the cause and effect. Thus, experts said rigorous clinical trials will have to be done in order to explore the issue some more per Mail Online.
A free meal worth as little as just $20 can influence the way a doctor decided to write a prescription. These are the findings of a new study published in the journal JAMA Internal Medicine.
Research shows that statins, or cholesterol-lowering drugs, reduces the risk of amputation and death in patients who are suffering from peripheral artery disease.
A new experimental drug that could benefit patients tolerant to statins has been announced this week. The drug is said to help prevent the production of LDL or bad cholesterol from the liver.
The pharmaceutical company Pfizer has found itself the subject of an ever-increasing number of lawsuits over allegations it misled people about the possible negative side effects of their popular cholesterol drug Lipitor.
